Besides neuroprotective effects, GLP-1 receptor agonists have been found to be involved in brain networks associated with reward and addiction
According to the recently completed ELIXA and LEADER trials, an increase in HR, regardless of its magnitude, does not appear to increase the cardiovascular risk of individuals with T2DM and with (or at high risk of) cardiovascular disease
Despite this potential, given the known long-term benefit of lowering hemoglobin A1c in preventing DR progression, there does not appear to be any contraindication to initiating GLP-1/GIP agonist therapy with appropriate ocular monitoring
Some effects like improved sleep may be noticed within the first week
Many contain harmful steroids or mercury that damage the skin barrier over time
Read each provider card for whether the price is medication-included, membership-plus-medication, insurance-routed, pharmacy-billed, prepaid, promotional, quote-based, or availability-limited